February 10, 2022 - February 15, 2022

Madhavbaug IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Madhavbaug IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	1	0
%	0.00	0.00	0.00	100.00	0.00

Madhavbaug IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Avoid

Madhavbaug IPO Review by Dilip Davda (Avoid)

[Dilip Davda] VSAL has posted erratic financial performance so far. It is priced exorbitantly based on its latest performance with super-profits. It is going to spend nearly 80% of IPO proceeds on advertising and branding which raises concern. There is no harm in ignoring this IPO. Read detail review...

Madhavbaug IPO Review by Members

Madhavbaug IPO Reviews, analysis and views by popular members. Read Vaidya Sane Ayurved Laboratories Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Madhavbaug IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.